CN1712060A - Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease - Google Patents
Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease Download PDFInfo
- Publication number
- CN1712060A CN1712060A CN 200510016910 CN200510016910A CN1712060A CN 1712060 A CN1712060 A CN 1712060A CN 200510016910 CN200510016910 CN 200510016910 CN 200510016910 A CN200510016910 A CN 200510016910A CN 1712060 A CN1712060 A CN 1712060A
- Authority
- CN
- China
- Prior art keywords
- radix
- preparation
- percolation
- rhizoma
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating the menstrual diseases of woman is prepared from 11 Chinese-medicinal materials including ginseng, Chinese angelica root, Chuan-xiong rhizome, motherwort, etc. Its preparing process is also disclosed.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of preparation method for the treatment of the Chinese medicine preparation of gynecologic menstrual disease, international Patent classificating number: A61K35/78, A61P29/00.
Background technology
Come from traditional classical name side " BAZHEN TANG ", have QI invigorating, nourish blood, the effect of regulating menstruation, be used for deficiency of both QI and blood, body nihility power, menoxenia, abdominal pain in menstruation.Dysmenorrhea is one of common gynecological disease, frequently-occurring disease.Through the investigation of physical constants cooperative groups, severe pain accounts for 13.5% through the patient according to national woman month, and moderate pain accounts for 38.81% through the patient.Particularly woman's menophania 1 year, incidence rate was about 75%.The morbidity of dysmenorrhea directly influences patient's work, studying and living.At present for the medicine of dysmenorrhes Western medicine and Chinese medicine two big classes are arranged at home, Western medicine is a NSAID (non-steroidal anti-inflammatory drug), and toxic and side effects is big.
" BAZHEN TANG " has long history and definite clinical efficacy in gynecopathy therapeutic, with the product of this recipe development bazhen yimu pills, bazhen yimu wan, norlutin etc. are arranged, but has all that dose is big, onset slow, takes shortcoming such as inconvenience.
Summary of the invention
Purpose of the present invention adopts supercritical extraction technique, membrane separation technique, provide a kind of rapid-action, bioavailability is high, dose is little, taking convenience, stay-in-grade a kind of preparation method for the treatment of the herb mixture of gynecologic menstrual disease.
The present invention adopts national drug standards WS
3The prescription of-B-2319-97 norlutin, its prescription is as follows:
Herba Leonuri 250g, Rhizoma Corydalis (vinegar system) 50g, Colla Corii Asini 25g,
Radix Angelicae Sinensis 100g, Radix Ginseng 50g, Radix Rehmanniae Preparata 125g,
The Radix Paeoniae Alba (processed with wine) 75g, Rhizoma Chuanxiong 75g, the Rhizoma Atractylodis Macrocephalae (stir-fry) 75g,
Poria 75g, Radix Glycyrrhizae (processed with honey) 50g;
The present invention is supercritical extraction technique, the membrane separation technique that adopts in the modern Chinese medicine production technology, and the above-mentioned raw materials medicine is prepared into mixture or oral liquid;
Preparation method:
1, Radix Ginseng, Rhizoma Corydalis, according to the percolation (2000 editions appendix IO of Chinese Pharmacopoeia) under fluid extract and the extractum item, Radix Ginseng is made solvent with 6～10 times of amount 50～70% ethanol, floods and carries out percolation after 24～48 hours, and percolation speed is 1～5ml/min/kg; Rhizoma Corydalis is made solvent with 6～10 times of amount 60～80% ethanol, floods and carries out percolation after 12～36 hours, and percolation speed is 1～5ml/min/kg.The collection liquid of filtering is standby;
2, Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae were carried volatile oil in 4～5 hours with steam distillation; Or use CO
2Supercritical extraction unit extraction volatile oil, extracting pressure 40～50Mpa, 40～50 ℃ of extraction temperature are resolved pressure 5～10Mpa, 50～60 ℃ of resolution temperatures, 2～6 hours time;
3, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae medicinal residues and Herba Leonuri, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae adds decocting in water three times, 1～3 hour for the first time, add 6～10 times of water gagings, 0.5～2 hour for the second time, add 4～8 times of water gagings, 0.5～2 hour for the third time, add 4～8 times of water gagings, filter, merging filtrate, being condensed into relative density is the clear paste of 1.15～1.20 (60 ℃), adds ethanol, make and contain alcohol amount and reach 50～60%, left standstill 12～36 hours, and filtered filtrate and Radix Ginseng, the liquid of filtering of Rhizoma Corydalis merges, with the molecular retention value is that 10,000 poly (ether sulfone) film separates, pressure 0.2～0.4Mpa, membrane flux 1000～3000ml/min, 20～40 ℃ of temperature, separate the back and reclaim ethanol, and be condensed into the clear paste that relative density is 1.10～1.20 (60 ℃);
4, Colla Corii Asini is added decocting in waterization, filter, filtrate is mixed with clear paste in 3;
5, correctives sucrose is made simple syrup, standby; Described correctives can be selected sucrose or Mel, preferably sucrose of the present invention; It is the 10-20 gram that per 100 milliliters of mixture contain the sucrose amount;
6, add 2～10ml Tween 80 in volatile oil, mixing adds medicinal liquid, simple syrup and sodium benzoate 3～9g, adds water to 2000ml, filter, and embedding, promptly.
Foundation of the present invention
1, prescription foundation
According to national drug standards WS
3The prescription of-B-2319-97 norlutin.The FUKANG mixture is formed by " BAZHEN TANG " plus-minus, in the side Herba Leonuri invigorate blood circulation, blood stasis dispelling, regulating menstruation, the water that disappears, promoting the circulation of blood and do not hinder fresh blood is nourished blood and the blood stasis that do not stagnate, and is monarch drug.The people participates in Radix Rehmanniae Preparata and matches, benefiting QI and nourishing blood and the blood stasis that do not stagnate, and the two is combined into ministerial drug.The Rhizoma Atractylodis Macrocephalae, Poria spleen invigorating eliminating dampness by diuresis, association's Radix Ginseng QI invigorating spleen reinforcing; Radix Angelicae Sinensis, Colla Corii Asini, the Radix Paeoniae Alba, the joint venture of nourishing blood helps the cloudy blood of Radix Rehmanniae Preparata tonification; Rhizoma Chuanxiong, Rhizoma Corydalis are invigorated blood circulation, circulation of qi promoting, pain relieving, make it tonify without causing stagnation, are adjuvant drug altogether.The Radix Glycyrrhizae Preparata QI invigorating and in, coordinating the actions of various ingredients in a prescription is messenger drug.Fang Zhongcan, art, Siberian cocklebur, grass, i.e. decoction of four noble drugs; Ground, Chinese herbaceous peony, return, rhizome of chuanxiong is SIWU TANG; The classic prescriptions of be respectively QI invigorating, enriching blood.All medicines share, QI invigorating, nourish blood, regulating menstruation.
2, adjuvant foundation
The screening of prescription adjuvant is according to " pharmaceutical necessities complete works " nineteen ninety-five front page;
Usage of the present invention and consumption: oral, each 10ml, 2 times on the one;
The present invention reaches the requirement of state-promulgated pharmacopoeia after tested.
Use the FUKANG mixture of the present invention's preparation, enter in patient's body, saved medicine disintegration time in vivo with the form of liquid, rapid-action; Mixture has increased the distribution area of medicine in gastrointestinal tract, has improved bioavailability, and mouthfeel is good, makes things convenient for the patient to take; The present invention uses supercritical extraction technique and extracts volatile oil, has overcome the volatile oil that exists in the traditional extraction process not easily collecting, shortcoming that oil yield is low, has improved the yield of volatile oil, and then has strengthened the curative effect of preparation; The present invention has adopted membrane separation technique in the preparation process, removed most of impurity, has strengthened stability of formulation, has improved product quality.
The specific embodiment
Embodiment 1:
Get Herba Leonuri 250g, Rhizoma Corydalis (vinegar system) 50g, Colla Corii Asini 25g, Radix Angelicae Sinensis 100g, Radix Ginseng 50g, Radix Rehmanniae Preparata 125g, the Radix Paeoniae Alba (processed with wine) 75g, Rhizoma Chuanxiong 75g, the Rhizoma Atractylodis Macrocephalae (stir-fry) 75g, Poria 75g, Radix Glycyrrhizae (processed with honey) 50g, sucrose 150～200g is standby;
Preparation technology:
1, Radix Ginseng, Rhizoma Corydalis adopt the percolation percolation, and Radix Ginseng is made solvent with 7 times of amount 55% ethanol, floods and carries out percolation after 26 hours, and percolation speed is 1ml/min/kg; Rhizoma Corydalis is made solvent with 6 times of amount 60% ethanol, floods and carries out percolation after 24 hours, and percolation speed is 4ml/min/kg.The collection liquid of filtering is standby;
2, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae CO
2Supercritical extraction unit extraction volatile oil, extracting pressure 41Mpa, 42 ℃ of extraction temperature are resolved pressure 6Mpa, 55 ℃ of resolution temperatures, 3 hours time;
3, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae medicinal residues and Herba Leonuri, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae adds decocting in water three times, 2 hours for the first time, adds 7 times of water gagings, 1 hour for the second time, add 5 times of water gagings, 1 hour for the third time, add 5 times of water gagings, filter, merging filtrate, being condensed into relative density is the clear paste of 1.15 (60 ℃), adds ethanol, make and contain alcohol amount and reach 52%, left standstill 24 hours, and filtered filtrate and Radix Ginseng, the liquid of filtering of Rhizoma Corydalis merges, with the molecular retention value is that 10,000 poly (ether sulfone) film separates, pressure 0.2Mpa, membrane flux 1800ml/min, 26 ℃ of temperature, separate the back and reclaim ethanol, and be condensed into the clear paste that relative density is 1.12 (60 ℃);
4, Colla Corii Asini is added decocting in waterization, filter, filtrate is mixed with clear paste in 3;
5, sucrose is made simple syrup, standby;
6, add the 5ml Tween 80 in volatile oil, mixing adds medicinal liquid, simple syrup and sodium benzoate 6g, adds water to 2000ml, filters, and embedding promptly gets the present invention.
Embodiment 2:
It is standby to get Herba Leonuri 250g, Rhizoma Corydalis (vinegar system) 50g, Colla Corii Asini 25g, Radix Angelicae Sinensis 100g, Radix Ginseng 50g, Radix Rehmanniae Preparata 125g, the Radix Paeoniae Alba (processed with wine) 75g, Rhizoma Chuanxiong 75g, the Rhizoma Atractylodis Macrocephalae (stir-fry) 75g, Poria 75g, Radix Glycyrrhizae (processed with honey) 50g, Mel 150～200g;
Preparation technology:
1, Radix Ginseng, Rhizoma Corydalis adopt the percolation percolation, and Radix Ginseng is made solvent with 10 times of amount 60% ethanol, floods and carries out percolation after 30 hours, and percolation speed is 3ml/min/kg; Rhizoma Corydalis is made solvent with 9 times of amount 70% ethanol, floods and carries out percolation after 24 hours, and percolation speed is 3ml/min/kg.The collection liquid of filtering is standby;
2, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae CO
2Supercritical extraction unit extraction volatile oil, extracting pressure 43Mpa, 45 ℃ of extraction temperature are resolved pressure 7Mpa, 54 ℃ of resolution temperatures, 4 hours time;
3, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae medicinal residues and Herba Leonuri, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae adds decocting in water three times, 2 hours for the first time, adds 8 times of water gagings, 1 hour for the second time, add 6 times of water gagings, 1 hour for the third time, add 6 times of water gagings, filter, merging filtrate, being condensed into relative density is the clear paste of 1.17 (60 ℃), adds ethanol, make and contain alcohol amount and reach 55%, left standstill 24 hours, and filtered filtrate and Radix Ginseng, the liquid of filtering of Rhizoma Corydalis merges, with the molecular retention value is that 10,000 poly (ether sulfone) film separates, pressure 0.3Mpa, membrane flux 2000ml/min, 30 ℃ of temperature, separate the back and reclaim ethanol, and be condensed into the clear paste that relative density is 1.15 (60 ℃);
4, Colla Corii Asini is added decocting in waterization, filter, filtrate is mixed with clear paste in 3;
5, with the Mel refining, standby;
6, add the 6ml Tween 80 in volatile oil, mixing adds medicinal liquid, refined honey and sodium benzoate 7g, adds water to 2000ml, filters, and embedding promptly gets the present invention.
Claims (5)
1, a kind of preparation method for the treatment of the herb mixture of gynecologic menstrual disease may further comprise the steps:
(1) by prescription take by weighing Herba Leonuri 250g, Rhizoma Corydalis (processed with vinegar) 50g, Colla Corii Asini 25g, Radix Angelicae Sinensis 100g, Radix Ginseng 50g, Radix Rehmanniae Preparata 125g, Radix Paeoniae Alba (processed with wine) 75g, Rhizoma Chuanxiong 75g, Rhizoma Atractylodis Macrocephalae (parched) 75g, Poria 75g, 50g is standby for the processed with honey Radix Glycyrrhizae;
(2) Radix Ginseng, Rhizoma Corydalis adopt the percolation percolation, and Radix Ginseng is made solvent with 6～10 times of amount 50～70% ethanol, floods and carries out percolation after 24～48 hours, and percolation speed is 1～5ml/min/kg; Rhizoma Corydalis is made solvent with 6～10 times of amount 60～80% ethanol, floods and carries out percolation after 12～36 hours, and percolation speed is 1～5ml/min/kg.The collection liquid of filtering is standby;
(3) Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae were carried volatile oil in 4～5 hours with steam distillation; Or use CO
2Supercritical extraction unit extraction volatile oil, extracting pressure 40～50Mpa, 40～50 ℃ of extraction temperature are resolved pressure 5～10Mpa, 50～60 ℃ of resolution temperatures, 2～6 hours time;
(4) with Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae medicinal residues and Herba Leonuri, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae adds decocting in water three times, 1～3 hour for the first time, add 6～10 times of water gagings, 0.5～2 hour for the second time, add 4～8 times of water gagings, 0.5～2 hour for the third time, add 4～8 times of water gagings, filter, merging filtrate is condensed into relative density and is 1.15～1.20 clear paste under 60 ℃, add ethanol, make and contain alcohol amount and reach 50～60%, left standstill 12～36 hours, and filtered filtrate and Radix Ginseng, the liquid of filtering of Rhizoma Corydalis merges, adopt poly (ether sulfone) film to separate, pressure 0.2～0.4Mpa, membrane flux 1000～3000ml/min, 20～40 ℃ of temperature, separate the back and reclaim ethanol, and to be condensed into relative density under 60 ℃ be 1.10～1.20 clear paste;
(5) Colla Corii Asini is added decocting in waterization, filter, filtrate is mixed with clear paste in the step 3;
(6) correctives sucrose is made simple syrup, standby;
(7) add 2～10ml Tween 80 in volatile oil, mixing adds medicinal liquid, simple syrup and sodium benzoate 3～9g, adds water to 2000ml, filter, and embedding, promptly.
2, preparation method according to claim 1 is characterized in that: described correctives can be selected sucrose or Mel, preferably sucrose of the present invention.
3, preparation method according to claim 1 is characterized in that: it is the 10-20 gram that per 100 milliliters of mixture contain the sucrose amount.
4, preparation method according to claim 1 is characterized in that: dosage form of the present invention is a mixture, or oral liquid.
5, preparation method according to claim 1 is characterized in that: the preferred CO of the present invention
2Supercritical extraction unit extraction volatile oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510016910XA CN100500183C (en) | 2005-06-23 | 2005-06-23 | Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510016910XA CN100500183C (en) | 2005-06-23 | 2005-06-23 | Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1712060A true CN1712060A (en) | 2005-12-28 |
| CN100500183C CN100500183C (en) | 2009-06-17 |
Family
ID=35717968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510016910XA Expired - Fee Related CN100500183C (en) | 2005-06-23 | 2005-06-23 | Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100500183C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623313B (en) * | 2009-01-22 | 2011-08-17 | 九芝堂股份有限公司 | Method for preparing traditional Chinese medicine preparation for tonifying blood |
| CN102499954A (en) * | 2011-12-28 | 2012-06-20 | 四川省旺林堂药业有限公司 | Norethindrone capsule |
| CN102824457A (en) * | 2012-06-04 | 2012-12-19 | 江西南昌桑海制药厂 | Eight-treasure motherwort active site and preparation process of capsules |
| CN106110166A (en) * | 2016-08-25 | 2016-11-16 | 西安必康制药集团有限公司 | A kind of medicine of benefiting QI and nourishing blood blood stasis dispersing and fresh blood promoting and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1490037A (en) * | 2003-08-08 | 2004-04-21 | 扬 余 | Chinese medicine for treating endocrinopathy |
| CN1244351C (en) * | 2003-08-25 | 2006-03-08 | 王永依 | Compound powder peparation for curing gynecopathy, its preparation method and application |
-
2005
- 2005-06-23 CN CNB200510016910XA patent/CN100500183C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623313B (en) * | 2009-01-22 | 2011-08-17 | 九芝堂股份有限公司 | Method for preparing traditional Chinese medicine preparation for tonifying blood |
| CN102499954A (en) * | 2011-12-28 | 2012-06-20 | 四川省旺林堂药业有限公司 | Norethindrone capsule |
| CN102824457A (en) * | 2012-06-04 | 2012-12-19 | 江西南昌桑海制药厂 | Eight-treasure motherwort active site and preparation process of capsules |
| CN106110166A (en) * | 2016-08-25 | 2016-11-16 | 西安必康制药集团有限公司 | A kind of medicine of benefiting QI and nourishing blood blood stasis dispersing and fresh blood promoting and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100500183C (en) | 2009-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101837065B (en) | Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof | |
| CN101099763A (en) | Traditional Chinese medicine for treating headache | |
| CN102145128A (en) | Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof | |
| CN103621869A (en) | Giant salamander oligosaccharide peptide health-care product | |
| CN104013929B (en) | Rheumatism pain relief medicine for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN105267559B (en) | A kind of drug and preparation method thereof for treating diabete peripheral herve pathology | |
| CN100500183C (en) | Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease | |
| CN1927324A (en) | Preparation method of traditional medicine preparation for treating women's menoxenia | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN109876127B (en) | Blood-nourishing angelica sinensis capsule and preparation method thereof | |
| CN108514627B (en) | A kind of traditional Chinese medicine composition for treating chronic urticaria | |
| KR20220121247A (en) | Compound preparation for nerve regeneration and method and use thereof | |
| CN1059117C (en) | Katsutoxin pill for tumor and preparing method thereof | |
| CN1238028C (en) | Method for preparing capsule of six drugs containing rehmannine | |
| CN1060051C (en) | Anti-cancer compn. and prepn. thereof | |
| CN1036503C (en) | Medicine for treating systemic lupus erythematosus and producing method thereof | |
| CN1201811C (en) | Chinese medicine composition for treating myopia and preparing method thereof | |
| CN102973817A (en) | Compound traditional Chinese medicine preparation for treating atherosclerosis, and preparation method thereof | |
| CN100475248C (en) | A medicine for treating metrorrhagia and preparation process thereof | |
| CN1692938A (en) | A compound preparation of traditional Chinese medicine for improving eyesight and its preparation method | |
| CN1709478A (en) | Method for preparing Chinese medicine formulation for treating gynaecological disease | |
| CN1279965C (en) | Traditional Chinese medicine preparation for treating cranial vascular diseases, its preparation method and application | |
| CN1189207C (en) | Chinese medicinal composition for improving human immunity and its preparation method | |
| CN117959387A (en) | Traditional Chinese medicine composition for treating hypertension, preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Tongyao Pharmaceutical Group Corp. Assignor: Xiu Laigui Contract fulfillment period: 2009.4.20 to 2019.4.20 Contract record no.: 2009220000016 Denomination of invention: Preparation of Chinese medicinal mixture for treating gynecologic menstrual disease Granted publication date: 20090617 License type: Exclusive license Record date: 20090615 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.4.20 TO 2019.4.20; CHANGE OF CONTRACT Name of requester: TONGYAO PHARMACEUTICAL GROUP CO., LTD. Effective date: 20090615 |
|
| ASS | Succession or assignment of patent right |
Owner name: JILIN XIUZHENG PHARMACEUTICAL NEW MEDICINE DEVELOP Free format text: FORMER OWNER: XIU LAIGUI Effective date: 20150525 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 130012 CHANGCHUN, JILIN PROVINCE TO: 130103 CHANGCHUN, JILIN PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150525 Address after: 130103 No. 1369 Shunda Road, hi tech Development Zone, Jilin, Changchun Patentee after: JILIN XIUZHENG PHARMACEUTICAL NEW MEDICINE DEVELOPMENT Co.,Ltd. Address before: 130012 No. 2426 Qianjin Street, Changchun hi tech Development Zone, Jilin, China Patentee before: Xiu Laigui |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090617 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |